ProCE Banner Activity

Rationales for Using Immunotherapy-Based Regimens in Advanced Endometrial Cancer

Slideset

Download these slides to review the biologic rationales for using established and investigational immunotherapy-based regimens in the treatment of advanced endometrial cancer.

Released: October 23, 2023

Share

Faculty

Ritu Salani

Ritu Salani, MD, MBA

Director, Division of Gynecologic Oncology
Professor, Department of Obstetrics and Gynecology
David Geffen School of Medicine at UCLA
Los Angeles, California

Lauren Prescott

Lauren Prescott, MD, MPH

Assistant Professor, Obstetrics and Gynecology
Division of Gynecologic Oncology
Vanderbilt University Medical Center
Nashville, Tennessee

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from GSK.

GSK